Faculty profile

André-Guy Martin

Back to faculty

Clinical ProfessorCancer Research CentreUniversité Laval

André-Guy Martin

Clinical Professor

Cancer Research Centre

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Clinical faculty often co-supervise; many graduate programs need a core faculty member as the main supervisor.
60 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

222

Publications

2,353

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université Laval profile.

Latest papers

Incidence of Lung Malignancy After Loose Brachytherapy Seed Migration Outside the Prostate: A Retrospective Cohort Study
SSRN Electronic Journal · 2026
Interobserver Study on HDR Prostate-Human-Selected Versus AI-Selected Plans.
Advances in radiation oncology · 2026
Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial.
European urology · 2025

All 222 publications

Latest funding

The impact of Monte Carlo dose calculations on prostate and breast low-dose rate brachytherapy dose-outcome relationships and radiobiological modeling.
CIHR · 2020 · Co-investigator
$715,276

All 1 grants and awards

From the 150 most recent of 222 publications.

Incidence of Lung Malignancy After Loose Brachytherapy Seed Migration Outside the Prostate: A Retrospective Cohort Study

Cédric Charrois-Durand, Brandon Morales, Damien Carignan, Philippe Després, Marie‐Claude Lavallée, Sylviane Aubin, Luc Beaulieu, William Foster, André‐Guy Martin, Éric Vigneault

SSRN Electronic Journal2026Open Access

DOI: 10.2139/ssrn.7322562

Interobserver Study on HDR Prostate-Human-Selected Versus AI-Selected Plans.

Chatigny PY, Lacroix F, Aubin S, Martin AG, Vigneault É, Bachand F, Foster W, Poulin É, Beaulieu L

Advances in radiation oncology2026Open Access

DOI: 10.1016/j.adro.2026.102132 PMID: 42761724

Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial.

Niazi T, Nabid A, Malagon T, Tisseverasinghe S, Bettahar R, Dahmane R, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Mohiuddin M

European urology202513 citations

DOI: 10.1016/j.eururo.2024.08.032 PMID: 39271420

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.

Pollack A, Johnson M, Proudfoot J, Davicioni E, Dal Pra A, Simko J, Martin A-G, Lukka H, Angyalfi S, Michalski JM

Journal of Clinical Oncology20253 citations

DOI: 10.1200/jco.2025.43.5_suppl.399

Impact of testosterone recovery after androgen deprivation therapy on overall survival in patients with high-risk prostate cancer: Long-term data from a phase III trial.

Abdenour Nabid, Nathalie Carrier, André‐Guy Martin, Jean-Paul Bahary, Peter Vavassis, Sylvie Vass, Boris Bahoric, Robert Archambault, François Vincent, Rédouane Bettahar, Marie Duclos, Luís Souhami

Journal of Clinical Oncology20253 citations

DOI: 10.1200/jco.2025.43.5_suppl.310

2249 Pelvic ultra-hypofractionated vs conventionally fractionated IMRT with HDR brachytherapy boost in prostate cancer: PCS-XI trial interim (NCT05820633)

François Fabi, Juanita Crook, Sarah Rauth, Marjorie Joliecoeur, Annie Ébacher, Wayne Koll, Danny Duplan, Tamim Mohammad Niazi, Steven Tisseveransinghe, Peter Vavassis, Sindy Magnan, William Joseph Foster, Marie‐Anne Froment, Éric Vigneault, François Bachand, Bernard Lachance, Louis Archambault, Philippe Després, Luc Beaulieu, Eric C. Poulin, Marie‐Claude Lavallée, Sylviane Aubin, F. Lacroix, Damien Carignan, André‐Guy Martin

Radiotherapy and Oncology20251 citationsSenior author

DOI: 10.1016/s0167-8140(25)00935-1

A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapy

F. Lacroix, Éric Poulin, Cédric Bélanger, Sheila M. J. Aubin, D. Carignan, Éric Vigneault, André‐Guy Martin, François Bachand, Luc Beaulieu, William Foster

Brachytherapy20251 citations

DOI: 10.1016/j.brachy.2025.11.009 PMID: 41402166

The prognostic impact of prostate-specific antigen at 6 months after post-prostatectomy radiotherapy: An individual patient data analysis of two NRG oncology randomized trials.

Mohamad O, Swanson DM, Pollack A, Lukka H, Dal Pra A, Dayes IS, Martin A-G, Greenberg M, Balogh AG, Michalski JM

Journal of Clinical Oncology2025Open Access

DOI: 10.1200/jco.2025.43.5_suppl.254

MP39-01 IMPACT OF TESTOSTERONE RECOVERY ON OVERALL SURVIVAL AFTER ANDROGEN DEPRIVATION THERAPY IN LOCALIZED PROSTATE CANCER PATIENTS: LONG-TERM PROSPECTIVE DATA

Abdenour Nabid, Nathalie Carrier, Éric Vigneault, André‐Guy Martin, Jean-Paul Bahary, Thu Van Nguyen, Peter Vavassis, Sylvie Vass, Marc-André Brassard, Boris Bahoric, Robert Archambault, François Vincent, Rédouane Bettahar, Marie Duclos, Derek Wilke, Luís Souhami

The Journal of Urology2025

DOI: 10.1097/01.ju.0001110184.48142.9e.01

Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate (PCS VI)

Tamim Mohammad Niazi, François Vincent, Marjory Jolicoeur, Junaid Yousuf, Guila Delouya, André‐Guy Martin, Marie Duclos, Michael I. Lock, Boris Bahoric, Asim Kamran, Robert Archambault, A. Amjad, Abdenour Nabid

International Journal of Radiation Oncology*Biology*Physics2025Open Access

DOI: 10.1016/j.ijrobp.2025.06.1028

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

André-Guy Martin

Research

Latest papers

Latest funding

Incidence of Lung Malignancy After Loose Brachytherapy Seed Migration Outside the Prostate: A Retrospective Cohort Study

Interobserver Study on HDR Prostate-Human-Selected Versus AI-Selected Plans.

Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial.

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.

Impact of testosterone recovery after androgen deprivation therapy on overall survival in patients with high-risk prostate cancer: Long-term data from a phase III trial.

2249 Pelvic ultra-hypofractionated vs conventionally fractionated IMRT with HDR brachytherapy boost in prostate cancer: PCS-XI trial interim (NCT05820633)

A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapy

The prognostic impact of prostate-specific antigen at 6 months after post-prostatectomy radiotherapy: An individual patient data analysis of two NRG oncology randomized trials.

MP39-01 IMPACT OF TESTOSTERONE RECOVERY ON OVERALL SURVIVAL AFTER ANDROGEN DEPRIVATION THERAPY IN LOCALIZED PROSTATE CANCER PATIENTS: LONG-TERM PROSPECTIVE DATA

Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate (PCS VI)

The impact of Monte Carlo dose calculations on prostate and breast low-dose rate brachytherapy dose-outcome relationships and radiobiological modeling.

Frequent collaborators

Eric Vigneault

Luc Beaulieu

Himu Lukka

George Rodrigues

Juanita Crook

Rowan Thomson

Gerard Morton

Marc Gaudet

SLOBODAN DEVIC

Marylise Boutros

Michael Lock

Lucie Beaulieu

Maroie Barkati

Louis Archambault

Laurent Azoulay

Ian Stuart Dayes

Douglas Loblaw

Vincent Fradet

Josée Savard

Mario Chrétien